BMO Capital analyst Kostas Biliouris initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Market Perform rating and announces Price Target of $41.
Intuit (NASDAQ:INTU) reported quarterly earnings of $7.65 per share which beat the analyst consensus estimate of $7.58 by 0.92 percent. This is a 26.03 percent increase over earnings of $6.07 per share from the same
Reed's (NASDAQ:REED) reported quarterly losses of $(0.05) per share. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $13.72 million